Tag: neuroendocrine tumors

June 20, 2019 Off

Camurs gets FDA’s green light to kick off phase 3 testing of treatment of acromegaly and neuroendocrine tumors

Camurus will start with the Phase 3 study of once-monthly octreotide subcutaneous depot for treatment of acromegaly CAM2029.

September 28, 2015 Off

Afinitor (everolimus) tablets reduced the risk of progression of neuroendocrine tumors

By Dino Mustafić

Novartis has announced results of a Phase III pivotal study showing Afinitor (everolimus) tablets reduced the risk of progression by 52% vs placebo in patients with advanced, progressive, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin.